Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
, gene editing, and single-cell sequencing. Lab funding comes from the Leukemia and Lymphoma Society, the National Cancer Institute, and other foundations. As a successful candidate, you will: Conduct
-
single-cell RNA analysis, you will study cell-intrinsic characteristics of BAFF-R CAR-T correlated with responses that can be used as markers of clinical outcomes. · Skills that are used in the lab
-
microscopy and image analysis. Experience with image analysis software, basic statistics, and information technology. A working understanding of immunohistochemistry and cell staining. A basic understanding of
-
, shaping the future of medicine through cutting-edge research. The laboratories of Dr. Michael A. Caligiuri and Dr. Jianhua Yu in the Departments of Hematology & Hematopoietic Cell Transplantation and Immuno
-
validation studies according to an approved plan or protocol that are essential to the cGMP production of biomedical products, which involves cell culture and cell bank maintenance including appropriate and
-
cell culture and in vivo animal model research is preferred. · Proficiency with basic biochemical techniques, molecular biology skills and cell culture systems. · Experience working with
-
, single cell RNA sequencing and spatial transcriptomics to dissect biologic mechanisms related to radiation that influence the local immune response. This position offers the opportunity to be promoted
-
below: · https://www.ncbi.nlm.nih.gov/myncbi/1ZUMm9-Cb59Al/bibliography/public/ · Nature Cancer (2023), Blood (2022, 2019, 2019), Blood Cancer Journal (2022), Cell Stem Cell (2018). As a
-
seeking a Research Associate II to join the T Cell Therapeutics Research Laboratory. This role plays a vital part in our clinical immunotherapeutic programs, offering opportunities to work with leading-edge
-
Biology at City of Hope. We study processes within lymphocytes and those outside (in the immune microenvironment) that drive the development of lymphoid malignancies including B- and T- cell acute